Olmutinib

• Description:

  Olmutinib is a Novel Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorOlmutinib at 3 μM significantly reversed drug resistance mediated by ABCG2, but not by ABCB1 and ABCC1, by antagonizing the drug efflux function in ABCG2-overexpressing cells.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  486.6

• Molecular Formula:

  C26H26N6O2S

• Notes:

  Research use only, not for human use.

• Receptor:

  EGFR

• CAS Number:

  1802181-20-9